ArticleJournal of inflammation research2026
Identification and Validation of ISG20 as a Shared Immune-Related Crosstalk Marker in Rheumatoid Arthritis and Inflammatory Bowel Disease.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: There is a bidirectional association between rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). Patients with RA exhibit a higher prevalence of IBD, those with IBD are at a significantly increased risk of developing RA. The shared molecular mechanisms and key bridging molecules underlying remain to be explored. Methods: Transcriptomic datasets from GEO were analyzed using WGCNA, differential expression, and immune-related genes to identify shared RA-IBD signatures. Least Absolute Shrinkage and Selection Operator (LASSO) and Support Vector Machine-Recursive Feature Elimination (SVM-RFE), were employed to prioritize diagnostic markers. Single-cell RNA sequencing datasets were used to localize the cellular source of the hub gene. Subsequently, two independent large-scale peripheral blood datasets were retrieved to further provide transcriptomic profiles of circulating immune cells, serving as a "bridge" between RA and IBD. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed. Findings were validated using collagen-induced arthritis (CIA) and dextran sulfate sodium (DSS) mice models, as well as in vitro TNF-α stimulation of MH7A and Caco-2 cells. Results: Intersection analysis identified 19 core immune-driven genes shared between RA and IBD, both diseases are characterized by a highly activated immune profile, particularly T cell lineages. Among these, ISG20 emerged as a critical molecular link, exhibiting high diagnostic efficacy for RA and IBD. Single-cell transcriptomic analysis further revealed that ISG20 is predominantly expressed in T cell populations in both RA synovium and IBD colon. In peripheral blood datasets, 29 "bridge genes" were identified and found to be significantly enriched in chemokine signaling. Experimental validation confirmed that ISG20 mRNA levels were significantly upregulated in inflamed synovial tissues of CIA and colon of DSS mice, and in TNF-α-stimulated MH7A and Caco-2 cells. Conclusion: ISG20 serves as a crosstalk molecular link across the RA and IBD. These findings provide molecular landscape for shared pathogenesis and diagnostic window for patients predisposed to the RA-IBD co-occurrence clinical phenotype.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.